In addition, pharmacological PEMT inhibition may be beneficial in the treatment of obesity and type 2 diabetes with concomitant diet therapy with fat restriction or use of lipase inhibitors (Supplementary Fig. 18). Here, PEMT is linked to obesity due to melanocortin 4 receptor deficiency.